Address
300 Kimball Drive
Parsippany, NJ 07054
United States of America (the)
Phone
201 847 6880
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2000
First IPO Date
March 22, 2022
| Name | Title | Pay | Year Born |
| Devdatt Kurdikar | President, CEO & Chairman | 2.4M | 1969 |
| Anthony Roth | Vice President, Chief Accounting Officer & Corporate Controller | 645,161 | 1973 |
| Jean Casner | Senior Vice President & Chief Human Resources Officer | 854,983 | 1958 |
| Jeffrey Z. Mann | Senior Vice President, General Counsel, Head of Business Development & Corporate Secretary | 1.11M | 1972 |
| Jacob Elguicze | Senior Vice President & Chief Financial Officer | 1.16M | 1973 |
| Shaun Curtis | Senior Vice President of Global Manufacturing & Supply Chain | 1.17M | 1970 |
| Pravesh Khandelwal | Vice President & Head of Investor Relations | 0 | N/A |
| Slobodan Radumilo | Senior Vice President & President of International | 0 | 1971 |
| Tom Blount | Senior Vice President & President of North America | 0 | 1974 |
| Ginny Blocki | Senior Vice President of Strategy | 0 | N/A |
Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 1924, Embecta's headquarters are located in Parsippany, New Jersey. The company transitioned to an independent entity from Becton, Dickinson and Company on April 1, 2022.